MSP Recovery Inc
NASDAQ:LIFW
MSP Recovery Inc
NASDAQ:LIFW
Price:
2.87
USD
-1.71%
Market Closed
Market Cap:
$20.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
MSP Recovery Inc
NASDAQ:LIFW
|
US |
|
E
|
East Stone Acquisition Corp
NASDAQ:NWTN
|
US |
|
D
|
Dof Robotik Sanayi AS
IST:DOFRB.E
|
TR |
|
Scryb Inc
OTC:SCYRD
|
CA |
|
S
|
Square Technology Group Co Ltd
SSE:603339
|
CN |
|
Addex Therapeutics Ltd
SIX:ADXN
|
CH |
|
I
|
Intel Corp
XETRA:INL
|
US |
|
Z
|
Zacapa Resources Ltd
XTSX:ZACA
|
CA |
|
P
|
Playfair Mining Ltd
OTC:PLYFF
|
CA |
|
Solytech Enterprise Corp
TWSE:1471
|
TW |
|
AVEVA Group PLC
LSE:AVV
|
UK |
|
L
|
Linkage Software Co Ltd
SSE:688588
|
CN |
|
Blue Owl Capital Corp
NYSE:OBDC
|
US |
|
Stelco Holdings Inc
TSX:STLC
|
CA |
|
I-PEX Inc
TSE:6640
|
JP |
|
Texmaco Infrastructure & Holdings Ltd
NSE:TEXINFRA
|
IN |
|
Ken Holding Co Ltd
SZSE:300126
|
CN |
|
Major Drilling Group International Inc
TSX:MDI
|
CA |
|
F
|
Fortescue Ltd
XMUN:FVJ
|
AU |
|
Samator Indo Gas Tbk PT
IDX:AGII
|
ID |
Relative Value
There is not enough data to reliably calculate the relative value of LIFW.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LIFW
Relative Value
Base Case
Not Available
Multiples Across Competitors
LIFW Competitors Multiples
MSP Recovery Inc Competitors
MSP Recovery Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
MSP Recovery Inc
NASDAQ:LIFW
|
20.3m USD | 1.9 | -0.2 | -14.8 | -1.4 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
92.5B USD | 0.2 | 52.3 | 13.6 | 13.6 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
66.4B EUR | 0.3 | 13.1 | 7.7 | 9.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
70B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.9B EUR | 1.1 | 19.9 | 9.4 | 14 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.3B EUR | 1.1 | 22.8 | 8.8 | 16.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD | 1.6 | 24.9 | 12 | 17.4 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 2 | 21.8 | 11.8 | 15.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.6B EUR | 0.5 | 10.9 | 5.3 | 9.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
10.9B USD | 11.1 | -26.2 | -28.7 | -26.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.5B USD | 0.8 | 14.1 | 7.2 | 9.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
